Overview
Silicon Laboratories Inc., based in the United States, operates primarily in the semiconductor industry, focusing on the development of silicon, software, and solutions for a smarter, more connected world. Their work spans the creation of microcontrollers, wireless chips, and sensors, aimed predominantly at applications within the Internet of Things (IoT), infrastructure, industrial automation, consumer, and automotive sectors. Key projects typically involve innovation in energy-friendly technologies that enhance connectivity and performance, with a particular emphasis on the development of low-power wireless technologies for emerging IoT networks. Silicon Laboratories endeavors to drive the transformation in the industry by delivering advanced, integrated solutions that tackle modern technological challenges.
Basic Stats
The Factor Analysis chart (below right) shows a view of Silicon Laboratories Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 43.83 MM |
| Earnings Date | |
| EPS (TTM) | 0.29 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | 8.00 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | 0.01 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 4.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Silicon Laboratories Inc. is MX$168.98. The forecasts range from a low of MX$141.40 to a high of MX$199.50. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-04-02 | 2024-04-02 | 199.50 | 141.40 | 168.30 | 168.98 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Silicon Laboratories Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-05-27 | Benchmark | Buy | Buy | Reiterate |
| 2025-04-22 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-25 | Citigroup | Neutral | Neutral | Maintains |
| 2024-04-25 | Benchmark | Hold | Reiterate | |
| 2024-04-25 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-04-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-19 | Stifel | Buy | Buy | Maintains |
| 2023-07-31 | Citigroup | Neutral | Neutral | Maintains |
| 2023-07-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-27 | Keybanc | Overweight | Overweight | Maintains |
| 2023-07-07 | Raymond James | Market Perform | Initiate | |
| 2023-05-31 | Citigroup | Neutral | Neutral | Maintains |
| 2023-04-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-27 | TD Cowen | Outperform | Maintains | |
| 2023-04-27 | Keybanc | Overweight | Maintains | |
| 2023-02-07 | Citigroup | Neutral | Maintains | |
| 2023-02-02 | Wells Fargo | Overweight | Maintains | |
| 2023-02-02 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-02 | Summit Insights Group | Hold | Buy | Upgrade |
| 2023-02-02 | Keybanc | Overweight | Maintains | |
| 2023-01-23 | Barclays | Underweight | Maintains | |
| 2023-01-09 | Wells Fargo | Overweight | Maintains | |
| 2022-10-27 | Barclays | Underweight | Maintains | |
| 2022-10-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-27 | Keybanc | Overweight | Maintains | |
| 2022-10-27 | Needham | Buy | Hold | Downgrade |
| 2022-10-24 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2022-07-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-28 | Summit Insights Group | Buy | Hold | Downgrade |
| 2022-07-28 | Needham | Buy | Maintains | |
| 2022-07-11 | Wells Fargo | Overweight | Maintains | |
| 2022-04-28 | Needham | Buy | Maintains | |
| 2022-04-28 | Keybanc | Overweight | Maintains | |
| 2022-04-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-07 | Needham | Buy | Maintains | |
| 2021-12-21 | Wells Fargo | Overweight | Maintains | |
| 2021-12-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-12 | Stifel | Buy | Maintains | |
| 2021-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-28 | Barclays | Equal-Weight | Maintains | |
| 2021-10-28 | Needham | Buy | Maintains | |
| 2021-10-28 | Keybanc | Overweight | Maintains | |
| 2021-07-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-05-19 | Citigroup | Buy | Neutral | Downgrade |
| 2021-04-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-04-29 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-04-23 | Keybanc | Sector Weight | Overweight | Upgrade |
| 2021-02-24 | Wells Fargo | Overweight | Maintains | |
| 2021-02-22 | Benchmark | Buy | Maintains | |
| 2021-02-22 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-02-22 | Needham | Buy | Maintains | |
| 2021-02-04 | Loop Capital | Hold | Maintains | |
| 2021-02-04 | Needham | Buy | Maintains | |
| 2021-02-04 | Roth Capital | Buy | Maintains | |
| 2021-01-19 | Morgan Stanley | Equal-Weight | Initiate | |
| 2021-01-04 | Roth Capital | Buy | Maintains | |
| 2020-07-30 | Citigroup | Buy | Maintains | |
| 2020-07-20 | Barclays | Equal-Weight | Maintains | |
| 2020-04-30 | Benchmark | Buy | Maintains | |
| 2020-04-17 | Barclays | Equal-Weight | Maintains | |
| 2020-03-13 | Needham | Buy | Maintains | |
| 2020-03-13 | Citigroup | Buy | Maintains | |
| 2020-03-05 | Needham | Hold | Buy | Upgrade |
| 2020-01-30 | Citigroup | Buy | Maintains | |
| 2024-04-25 | Needham | Hold | Buy | Upgrade |
| 2024-02-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-08 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-01-16 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-01-02 | Stifel | Buy | Buy | Maintains |
| 2023-12-08 | JP Morgan | Overweight | Initiate | |
| 2023-11-02 | Keybanc | Overweight | Overweight | Maintains |
| 2023-11-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-02 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2023-10-30 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2020-01-29 | Summit Insights Group | Buy | Hold | Downgrade |
| 2019-12-20 | Wells Fargo | Overweight | Maintains | |
| 2019-07-23 | Benchmark | Buy | Initiate | |
| 2019-06-25 | Wells Fargo | Outperform | Initiate | |
| 2019-01-31 | Needham | Buy | Hold | Downgrade |
| 2018-10-25 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-10-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-06-22 | Loop Capital | Hold | Initiate | |
| 2018-06-15 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-05-17 | Cowen & Co. | Outperform | Initiate | |
| 2018-04-26 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-04-06 | Benchmark | Buy | Initiate | |
| 2017-10-26 | Canaccord Genuity | Buy | Maintains | |
| 2017-10-26 | B. Riley | Buy | Maintains | |
| 2017-10-18 | Barclays | Overweight | Maintains | |
| 2017-10-12 | Stifel Nicolaus | Buy | Maintains | |
| 2017-10-10 | Canaccord Genuity | Buy | Maintains | |
| 2017-02-01 | Needham | Hold | Buy | Upgrade |
| 2016-10-27 | MKM Partners | Neutral | Buy | Upgrade |
| 2016-09-29 | Roth Capital | Buy | Initiate | |
| 2016-07-28 | Citigroup | Buy | Maintains | |
| 2016-04-28 | Stephens & Co. | Equal-Weight | Maintains | |
| 2016-03-14 | MKM Partners | Neutral | Maintains | |
| 2016-03-01 | Drexel Hamilton | Buy | Initiate | |
| 2016-02-04 | Citigroup | Buy | Maintains | |
| 2015-10-29 | Canaccord Genuity | Buy | Maintains | |
| 2015-10-29 | William Blair | Outperform | Market Perform | Downgrade |
| 2015-10-29 | B. Riley FBR | Buy | Maintains | |
| 2015-09-25 | MKM Partners | Buy | Neutral | Downgrade |
| 2015-05-06 | Needham | Hold | Initiate | |
| 2015-04-30 | Citigroup | Buy | Maintains | |
| 2015-02-26 | Stifel Nicolaus | Buy | Maintains | |
| 2015-02-05 | Citigroup | Buy | Maintains | |
| 2015-02-04 | Topeka | Hold | Buy | Upgrade |
| 2014-10-24 | Citigroup | Buy | Maintains | |
| 2014-10-13 | Pacific Crest | Outperform | Sector Perform | Downgrade |
| 2014-08-08 | Canaccord Genuity | Buy | Initiate | |
| 2014-07-28 | Citigroup | Buy | Maintains | |
| 2014-07-08 | MKM Partners | Buy | Initiate | |
| 2014-04-30 | Topeka | Hold | Maintains | |
| 2014-04-30 | B. Riley FBR | Buy | Maintains | |
| 2014-04-30 | Citigroup | Buy | Maintains | |
| 2014-04-22 | Citigroup | Buy | Maintains | |
| 2014-02-20 | Stifel Nicolaus | Buy | Maintains | |
| 2014-01-31 | Citigroup | Buy | Maintains | |
| 2013-05-06 | Topeka | Hold | Initiate | |
| 2013-04-11 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2013-01-31 | UBS | Buy | Maintains | |
| 2013-01-30 | FBR Capital | Market Perform | Maintains | |
| 2013-01-30 | PiperJaffray | Overweight | Maintains | |
| 2013-01-30 | Wunderlich | Buy | Maintains | |
| 2013-01-03 | Barclays | Equal-Weight | Maintains | |
| 2012-12-13 | Citigroup | Buy | Maintains | |
| 2012-10-25 | Barclays | Equal-Weight | Maintains | |
| 2012-10-24 | Caris & Co. | Above Average | Buy | Upgrade |
| 2012-10-24 | FBR Capital | Market Perform | Maintains | |
| 2012-10-08 | Caris & Co. | Average | Above Average | Upgrade |
| 2012-09-18 | Miller Tabak | Buy | Neutral | Downgrade |
| 2012-09-12 | Williams Financial | Hold | Buy | Upgrade |
| 2012-07-25 | PiperJaffray | Overweight | Maintains | |
| 2012-07-23 | UBS | Buy | Maintains | |
| 2012-05-18 | UBS | Buy | Maintains | |
| 2012-04-26 | UBS | Buy | Maintains | |
| 2012-04-25 | FBR Capital | Market Perform | Maintains | |
| 2025-02-05 | Benchmark | Hold | Buy | Upgrade |
| 2025-02-05 | Needham | Buy | Buy | Maintains |
| 2025-03-12 | Needham | Buy | Buy | Reiterate |
| 2025-03-12 | Benchmark | Buy | Buy | Reiterate |
| 2024-12-17 | Susquehanna | Neutral | Initiate | |
| 2024-07-25 | Needham | Buy | Buy | Reiterate |
| 2025-07-08 | Keybanc | Overweight | Overweight | Maintains |
| 2024-11-05 | Stifel | Buy | Buy | Maintains |
| 2024-11-05 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-05 | Benchmark | Hold | Reiterate | |
| 2024-11-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-05 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-06 | Stifel | Buy | Buy | Maintains |
| 2025-01-22 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-17 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-14 | Susquehanna | Neutral | Neutral | Maintains |
| 2025-05-14 | Needham | Buy | Buy | Reiterate |
| 2025-05-14 | Benchmark | Buy | Buy | Reiterate |
| 2025-04-17 | Stifel | Buy | Buy | Maintains |
| 2025-08-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-18 | Stifel | Buy | Buy | Maintains |
| 2025-07-22 | Susquehanna | Neutral | Neutral | Maintains |
